
|Articles|January 5, 2015
The EORTC Board cordially invites you to a Plenary Session in honor of Francoise Meunier
At the Crowne Plaza Brussels - Le Palace on 12 March 2015 at 16:00
Advertisement
After 24 years of dedicated service as EORTC Director General with a major commitment to the management of pan-European cancer research, Françoise Meunier will continue her activities from 1st April 2015 as EORTC Director Special Projects.
Program
- General introduction - Roger Stupp (CH)
- Françoise Meunier’s implication in research on “Fungal infections” - Peter Donnelly (NL)
- Françoise Meunier as EORTC Director General - Alexander Eggermont (FR)
- The patients perspectives and survival issues - Isabelle Lebrocquy (NL)
- Cancer management and transatlantic cooperation - Richard Schilsky (USA)
- The EORTC Charitable Trust - Diego du Monceau de Bergendal (BE)
- EORTC future perspectives - Roger Stupp (CH)
Followed by a reception and walking dinner at Palais d’Egmont at 19:00
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5




